What does APOTHEEK HEUVEN do?

APOTHEEK HEUVEN is a pharmacy in Zonhoven. Public Limited, started on 20 December 2001, 1 establishment.

What is the address of APOTHEEK HEUVEN?

The registered office of APOTHEEK HEUVEN is located at Heuvenstraat 76, 3520 Zonhoven.

Is APOTHEEK HEUVEN still active?

Yes. According to the CBE (31 October 2026) APOTHEEK HEUVEN is active, legal situation “Normale toestand”, started on 20 December 2001.

Is APOTHEEK HEUVEN registered on Peppol?

Yes, APOTHEEK HEUVEN is registered on the Peppol network with ID 0208:0476383430.

What is the enterprise number of APOTHEEK HEUVEN?

The enterprise number of APOTHEEK HEUVEN is BE0476383430.

When was APOTHEEK HEUVEN founded?

APOTHEEK HEUVEN was founded on 20 December 2001.

Who are the directors of APOTHEEK HEUVEN?

According to the 2025 annual accounts, the directors of APOTHEEK HEUVEN are: Giorgio Pluchino, MAJORANA INVESTMENTS BV.

Is APOTHEEK HEUVEN a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 20 December 2001; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did APOTHEEK HEUVEN make in 2025?

APOTHEEK HEUVEN posted a profit after taxes of € 7,726 in financial year 2025.

What is the revenue of APOTHEEK HEUVEN?

As a small company, APOTHEEK HEUVEN is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 243,600.

How much does an employee at APOTHEEK HEUVEN earn?

The average wage cost per full-time employee at APOTHEEK HEUVEN was € 65,200 in 2025: staff costs of € 156,567 for 2.4 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does APOTHEEK HEUVEN have?

According to the 2025 annual accounts, APOTHEEK HEUVEN has 2.4 full-time equivalents (FTE).

APOTHEEK HEUVEN (Public Limited) - Zonhoven

Dossier APOTHEEK HEUVEN, printed on 31 October 2026 from databakkes.be/en/0476383430/apotheek-heuven. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

APOTHEEK HEUVEN from Zonhoven, company number BE0476383430, closed financial year 2025 with a result of € 7,726 after tax. For that financial year APOTHEEK HEUVEN recorded a gross margin of € 243,600 and equity of € 518,733. Compared with financial year 2024, the result moved from € 30,650 to € 7,726. The company is profitable. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on June 23, 2026.

What it is worth Growing

€ 518,733

▲ 2% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 7,726

▼ 75% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 420,190

▲ 19% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 332,813.

People and assets in 2025

Full-time equivalents

2.4

▲ 0.1 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 156,567

▼ 6% vs 2024

€ 65,200 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 113,480

▼ 9% vs 2024

Of which on lease € 104,153.

Debts at end 2025

Bank debt ≈ 13 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 763,564

▼ 7% vs 2024

€ 60,431 is repaid this year. At this pace the long-term loan is gone in ≈ 13 years.

Owed to suppliers

€ 293,319

▲ 29% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 28,073

▼ 21% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 520,452 Gross margin 2022: € 520,452 First fiscal year in the series	€ 137,564 Gross margin 2023: € 137,564 ▼ 74% vs 2022 (€ 520,452) Unfavourable step	€ 278,314 Gross margin 2024: € 278,314 ▲ 102% vs 2023 (€ 137,564) Favourable step	€ 243,600 Gross margin 2025: € 243,600 ▼ 12% vs 2024 (€ 278,314) Unfavourable step	▼ 12%
Profit after taxes	€ 302,653 Profit after taxes 2022: € 302,653 First fiscal year in the series	€ -56,708 Profit after taxes 2023: € -56,708 ▼ € 359,360 vs 2022 (€ 302,653) Unfavourable step	€ 30,650 Profit after taxes 2024: € 30,650 ▲ € 87,357 vs 2023 (€ -56,708) Favourable step	€ 7,726 Profit after taxes 2025: € 7,726 ▼ 75% vs 2024 (€ 30,650) Unfavourable step	▼ 75%
Equity	€ 537,065 Equity 2022: € 537,065 First fiscal year in the series	€ 480,357 Equity 2023: € 480,357 ▼ 11% vs 2022 (€ 537,065) Unfavourable step	€ 511,007 Equity 2024: € 511,007 ▲ 6% vs 2023 (€ 480,357) Favourable step	€ 518,733 Equity 2025: € 518,733 ▲ 2% vs 2024 (€ 511,007) Favourable step	▲ 2%
Total debts	€ 624,426 Total debts 2022: € 624,426 First fiscal year in the series	€ 1,139,668 Total debts 2023: € 1,139,668 ▲ 83% vs 2022 (€ 624,426) Unfavourable step	€ 1,169,064 Total debts 2024: € 1,169,064 ▲ 3% vs 2023 (€ 1,139,668) Unfavourable step	€ 1,168,370 Total debts 2025: € 1,168,370 Unchanged (€ 1,169,064) Favourable step
Cash	€ 424,826 Cash 2022: € 424,826 First fiscal year in the series	€ 218,922 Cash 2023: € 218,922 ▼ 48% vs 2022 (€ 424,826) Unfavourable step	€ 351,834 Cash 2024: € 351,834 ▲ 61% vs 2023 (€ 218,922) Favourable step	€ 420,190 Cash 2025: € 420,190 ▲ 19% vs 2024 (€ 351,834) Favourable step	▲ 19%
Land & buildings	€ 399,460 Land & buildings 2022: € 399,460 First fiscal year in the series	€ 778,381 Land & buildings 2023: € 778,381 ▲ 95% vs 2022 (€ 399,460) Unchanged	€ 748,862 Land & buildings 2024: € 748,862 ▼ 4% vs 2023 (€ 778,381) Unchanged	€ 719,343 Land & buildings 2025: € 719,343 ▼ 4% vs 2024 (€ 748,862) Unchanged	▼ 4%
Retained profit	€ 351,145 Retained profit 2022: € 351,145 First fiscal year in the series	€ 294,437 Retained profit 2023: € 294,437 ▼ 16% vs 2022 (€ 351,145) Unfavourable step	€ 325,087 Retained profit 2024: € 325,087 ▲ 10% vs 2023 (€ 294,437) Favourable step	€ 332,813 Retained profit 2025: € 332,813 ▲ 2% vs 2024 (€ 325,087) Favourable step	▲ 2%
Bank debt	€ 396,559 Bank debt 2022: € 396,559 First fiscal year in the series	€ 879,222 Bank debt 2023: € 879,222 ▲ 122% vs 2022 (€ 396,559) Unfavourable step	€ 822,084 Bank debt 2024: € 822,084 ▼ 6% vs 2023 (€ 879,222) Favourable step	€ 763,564 Bank debt 2025: € 763,564 ▼ 7% vs 2024 (€ 822,084) Favourable step	▼ 7%
Balance sheet total	€ 1,245,726 Balance sheet total 2022: € 1,245,726 First fiscal year in the series	€ 1,701,936 Balance sheet total 2023: € 1,701,936 ▲ 37% vs 2022 (€ 1,245,726) Unchanged	€ 1,759,657 Balance sheet total 2024: € 1,759,657 ▲ 3% vs 2023 (€ 1,701,936) Unchanged	€ 1,764,364 Balance sheet total 2025: € 1,764,364 Unchanged (€ 1,759,657) Unchanged
Employees (FTE)	2.6 Employees (FTE) 2022: 2.6 First fiscal year in the series	2.4 Employees (FTE) 2023: 2.4 ▼ 0.2 vs 2022 (2.6) Unchanged	2.3 Employees (FTE) 2024: 2.3 ▼ 0.1 vs 2023 (2.4) Unchanged	2.4 Employees (FTE) 2025: 2.4 ▲ 0.1 vs 2024 (2.3) Unchanged	▲ 0.1

Key figures of APOTHEEK HEUVEN, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to APOTHEEK HEUVEN?

What happened at APOTHEEK HEUVEN in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 23, 2026 New annual accounts for financial year 2025: profit of € 7,726 (▼ 75% vs 2024). Source: NBB ↗
2022 Giorgio Pluchino became a director. NBB
2022 MAJORANA INVESTMENTS BV became a director. NBB
Mar 6, 2002 New establishment in Zonhoven. KBO
Dec 20, 2001 Start of the company according to the CBE. KBO

In short

From € 302,653 profit in 2022 to € 7,726 profit in 2025.

Paid € 71 in corporate taxes since 2022.

Best year ever: 2022, with € 302,653 profit.

On average € 101,500 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

MAJORANA INVESTMENTS 100%

The stake of MAJORANA INVESTMENTS comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

APOTHEEK HEUVEN

Behind APOTHEEK HEUVEN are Giorgio Pluchino and MAJORANA INVESTMENTS BV. The shares are held by MAJORANA INVESTMENTS (100%).

Directors

According to the 2025 annual accounts

Giorgio Pluchino

Director

Also active at: MAJORANA INVESTMENTS

since 2022

MAJORANA INVESTMENTS BV

Director · represented by Pluchino Valentino

Also active at: APOTHEEK PLUCHINO

since 2022

Shareholders

MAJORANA INVESTMENTS

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Heuvenstraat 76

3520 Zonhoven

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0476.383.430

VAT number

BE 0476.383.430

Registered office

Heuvenstraat 76, 3520 Zonhoven

Names & denominations

APOTHEEK HEUVEN

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

20 December 2001

Peppol

Active · Active since 8 Oct 2025

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

Detailhandel in cosmetica en toiletartikelen

Detailhandel in medische en orthopedische artikelen

Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen

Detailhandel in medische en orthopedische artikelen in gespecialiseerde winkels

View on CBE Public ↗ Annual accounts (NBB) ↗

APOTHEEK HEUVEN

Financials

What happened to APOTHEEK HEUVEN?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Details

Frequently asked questions